Literature DB >> 18426831

Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome.

S Cupisti1, N Kajaia, R Dittrich, H Duezenli, M W Beckmann, A Mueller.   

Abstract

BACKGROUND: The aim of this study was to evaluate associations of clinical features, such as hirsutism, polycystic ovaries (PCOs), ovulatory dysfunction, and body mass index (BMI) > or =25 kg/m(2), with metabolic abnormalities in hyperandrogenic women.
METHODS: Hirsutism was based on the modified Ferriman-Gallwey score. Ovulatory function was classified as eumenorrhea, oligomenorrhea and amenorrhea, and PCOs were assessed using the ultrasound criteria recommended in the Rotterdam definition. An oral glucose tolerance test was performed. Different insulin resistance (IR) indices were calculated.
RESULTS: Hirsute women had significantly higher BMI, DHEA sulfate (DHEAS) and free androgen index (FAI), and significantly lower values for sex hormone-binding globulin (SHBG). Women with amenorrhea were younger in comparison to women with eumenorrhea and had significantly higher values for fasting insulin (FI) and 1- and 2-h insulin levels; lower values for glucose to insulin ratio (GIR), quantitative insulin sensitivity check index (QUICKI), and SHBG. Women with PCO had significantly higher levels of LH and low-density lipoprotein (LDL), whereas high-density lipoprotein (HDL) levels were significantly lower. Women with a BMI > or =25 kg/m(2) had significantly higher values for age, fasting plasma glucose, FI, and 1- and 2-h glucose and insulin levels, homeostatic model for assessment of IR (HOMA-IR), homeostatic model for assessment of B-cell function (HOMA-B), and FAI, whereas their GIR, insulin sensitivity index, QUICKI, SHBG, and HDL were significantly lower.
CONCLUSIONS: In women with hyperandrogenic syndrome, BMI> or =25 kg/m(2) and amenorrhea appear to be associated with severe endocrine and metabolic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18426831     DOI: 10.1530/EJE-07-0515

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  12 in total

1.  Ovarian hypertension: polycystic ovary syndrome.

Authors:  Rhonda Bentley-Lewis; Ellen Seely; Andrea Dunaif
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

Review 2.  Polycystic ovary syndrome.

Authors:  Zi-Jiang Chen; Yuhua Shi
Journal:  Front Med China       Date:  2010-08-12

Review 3.  Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.

Authors:  Amanda J Redig; Hidayatullah G Munshi
Journal:  Am J Med       Date:  2010-01       Impact factor: 4.965

4.  Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome.

Authors:  Elif Agacayak; Senem Yaman Tunc; Sibel Sak; Serdar Basaranoglu; Hatice Yüksel; Abdulkadir Turgut; Talip Gul
Journal:  Med Sci Monit       Date:  2015-08-20

5.  The correlation of aromatase activity and obesity in women with or without polycystic ovary syndrome.

Authors:  Jie Chen; Shanmei Shen; Yong Tan; Dong Xia; Yanjie Xia; Yunxia Cao; Wenjun Wang; Xiaoke Wu; Hongwei Wang; Long Yi; Qian Gao; Yong Wang
Journal:  J Ovarian Res       Date:  2015-03-22       Impact factor: 4.234

6.  Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study.

Authors:  Marzieh Rostami Dovom; Fahimeh Ramezani Tehrani; Shirin Djalalinia; Leila Cheraghi; Samira Behboudi Gandavani; Fereidoun Azizi
Journal:  PLoS One       Date:  2016-12-16       Impact factor: 3.240

7.  Clinical and Biochemical Characteristics in PCOS Women With Menstrual Abnormalities.

Authors:  Vasiliki Christodoulopoulou; Eftihios Trakakis; Vasilios Pergialiotis; Melpomeni Peppa; Charalampos Chrelias; Dimitrios Kassanos; Nikolaos Papantoniou
Journal:  J Family Reprod Health       Date:  2016-12

8.  A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).

Authors:  Maha H Daghestani; Mazin Daghestani; Mamoon Daghistani; Akmal El-Mazny; Geir Bjørklund; Salvatore Chirumbolo; Samar H Al Saggaf; Arjumand Warsy
Journal:  Lipids Health Dis       Date:  2018-08-21       Impact factor: 3.876

9.  Serum Anti-Müllerian Hormone Levels Were Negatively Associated With Body Fat Percentage in PCOS Patients.

Authors:  Er Luo; Jinxiao Zhang; Jiahui Song; Di Feng; Yaxin Meng; Hongyu Jiang; Da Li; Yuanyuan Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-04       Impact factor: 5.555

10.  Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls.

Authors:  Ferdous Mehrabian; Roya Kelishadi
Journal:  J Res Med Sci       Date:  2012-03       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.